MedCap AB (publ)
F:61MA

Watchlist Manager
MedCap AB (publ) Logo
MedCap AB (publ)
F:61MA
Watchlist
Price: 49.16 EUR -1.32% Market Closed
Market Cap: €727.9m

Intrinsic Value

The intrinsic value for MedCap AB (publ) (61MA) under the Base Case is hidden EUR. Compared with the current market price of 49.16 EUR, the stock appears hidden .

Intrinsic value calculated as an equal blend of DCF
Locked
and Multiples
Locked
Other reference points

Do our valuations actually work? See backtest results .

61MA Intrinsic Value
LOCKED
Unlock
Today vs. history

61MA looks overvalued.
But is it expensive by its own standards?

See how today’s valuation compares with 61MA’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor 61MA
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price €49.16
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Ask AI Assistant
What other research platforms think about 61MA?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is 61MA valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for MedCap AB (publ).

Explain Valuation
Alternatives to 61MA

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

What is the Intrinsic Value of one 61MA stock?

The intrinsic value for MedCap AB (publ) (61MA) under the Base Case is hidden EUR.

Is 61MA stock undervalued or overvalued?

Compared with the current market price of 49.16 EUR, the stock appears hidden.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett